Skip to main content

Advertisement

Log in

Expression and Significances of MTSS1 in Pancreatic Cancer

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Thus far, expression of metastasis suppressor 1 (MTSS1), its clinicopathologic and prognostic significances in pancreatic cancer (PC) remain unknown. Expression of MTSS1 was detected by Western blotting in PC cell lines, and by tissue microarray-based immunohistochemical staining in paired tumor and non-tumor samples from 242 patients with PC. Furthermore, the correlations between MTSS1 expression and clinicopathologic variables as well as overall survival were evaluated. In PC cell lines, MTSS1 was differentially expressed. In addition, MTSS1 expression was significantly lower in tumor than in non-tumor tissues (P < 0.001 in both McNemar and Mann–Whitney U tests). High tumoral expression of MTSS1 was closely associated with absence of lymph node metastasis (P = 0.023). Univariate analysis found that high MTSS1 expression in tumor tissues was a strong predictor of favorable overall survival in the whole cohort (P < 0.001). Besides, its impacts on prognosis were also observed in nine out of fourteen subgroups. Finally, MTSS1 expression was identified as an independent prognostic marker in the whole cohort (P = 0.031) as well as in six subgroups (P < 0.05), as shown by multivariate Cox regression test. Down-regulation of MTSS1 expression is evident in PC, and is associated with lymph node metastasis and poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362:1605–1617

    Article  CAS  PubMed  Google Scholar 

  2. Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T, Maguchi H, Yanagisawa A, Tanaka M (2012) Japan pancreatic cancer registry; 30th year anniversary: Japan pancreas society. Pancreas 41:985–992

    Article  PubMed  Google Scholar 

  3. Lee SR, Kim HO, Son BH, Yoo CH, Shin JH (2013) Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma. Hepatogastroenterology 60:358–362

    CAS  PubMed  Google Scholar 

  4. Pongprasobchai S, Pannala R, Smyrk TC, Bamlet W, Pitchumoni S, Ougolkov A, de Andrade M, Petersen GM, Chari ST (2008) Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer. Pancreatology 8:587–592

    Article  PubMed Central  PubMed  Google Scholar 

  5. Martin LK, Wei L, Trolli E, Bekaii-Saab T (2012) Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer. Med Oncol 29:3101–3107

    Article  CAS  PubMed  Google Scholar 

  6. Lee YG, Macoska JA, Korenchuk S, Pienta KJ (2002) MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4:291–294

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Wang Y, Zhou K, Zeng X, Lin J, Zhan X (2007) Tyrosine phosphorylation of missing in metastasis protein is implicated in platelet-derived growth factor-mediated cell shape changes. J Biol Chem 282:7624–7631

    Article  CAS  PubMed  Google Scholar 

  8. Saarikangas J, Mattila PK, Varjosalo M, Bovellan M, Hakanen J, Calzada-Wack J, Tost M, Jennen L, Rathkolb B, Hans W, Horsch M, Hyvönen ME, Perälä N, Fuchs H, Gailus-Durner V, Esposito I, Wolf E, de Angelis MH, Frilander MJ, Savilahti H, Sariola H, Sainio K, Lehtonen S, Taipale J, Salminen M, Lappalainen P (2011) Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia. J Cell Sci 124:1245–1255

    Article  CAS  PubMed  Google Scholar 

  9. Dawson JC, Bruche S, Spence HJ, Braga VM, Machesky LM (2012) Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1. PLoS One 7, e31141

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Parr C, Jiang WG (2009) Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 45:1673–1683

    Article  CAS  PubMed  Google Scholar 

  11. Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang Y, Zhang L, Jiang WG (2011) The impact of metastasis suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med 9:95

    Article  PubMed Central  PubMed  Google Scholar 

  12. Du P, Ye L, Ruge F, Yang Y, Jiang WG (2011) Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer. Anticancer Res 31:3205–3212

    CAS  PubMed  Google Scholar 

  13. Du P, Ye L, Li H, Yang Y, Jiang WG (2012) The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway. J Exp Ther Oncol 10:91–99

    CAS  PubMed  Google Scholar 

  14. Zhong J, Shaik S, Wan L, Tron AE, Wang Z, Sun L, Inuzuka H, Wei W (2013) SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget 4:2339–2353

    Article  PubMed Central  PubMed  Google Scholar 

  15. Wu W, Wang Z, Yang P, Yang J, Liang J, Chen Y, Wang H, Wei G, Ye S, Zhou Y (2014) MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Mol Cell Biochem 388:249–259

    Article  CAS  PubMed  Google Scholar 

  16. Wang Y, Liu J, Smith E, Zhou K, Liao J, Yang GY, Tan M, Zhan X (2007) Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas. Cancer Investig 25:79–86

    Article  Google Scholar 

  17. Liu K, Wang G, Ding H, Chen Y, Yu G, Wang J (2010) Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer 10:428

    Article  PubMed Central  PubMed  Google Scholar 

  18. Isaksson HS, Sorbe B, Nilsson TK (2014) Whole genome expression profiling of blood cells in ovarian cancer patients-prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14. Oncotarget 5(12):4040–4049

    Article  PubMed Central  PubMed  Google Scholar 

  19. Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Góes JC, Brentani MM (2005) Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 11:7434–7443

    Article  CAS  PubMed  Google Scholar 

  20. Wang D, Xu MR, Wang T, Li T, Zhu J (2011) MTSS1 overexpression correlates with poor prognosis in colorectal cancer. J Gastrointest Surg 15:1205–1212

    Article  PubMed  Google Scholar 

  21. Chen Q, Chen L, Zhao R, Yang XD, Imran K, Xing CG (2013) Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model. J Cancer Res Clin Oncol 139:1169–1178

    Article  CAS  PubMed  Google Scholar 

  22. Mertz KD, Pathria G, Wagner C, Saarikangas J, Sboner A, Romanov J, Gschaider M, Lenz F, Neumann F, Schreiner W, Nemethova M, Glassmann A, Lappalainen P, Stingl G, Small JV, Fink D, Chin L, Wagner SN (2014) MTSS1 is a metastasis driver in a subset of human melanomas. Nat Commun 5:3465

    Article  PubMed  Google Scholar 

  23. Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T (2006) Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97:64–71

    Article  CAS  PubMed  Google Scholar 

  25. Utikal J, Gratchev A, Muller-Molinet I, Oerther S, Kzhyshkowska J, Arens N, Grobholz R, Kannookadan S, Goerdt S (2006) The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer 119:2287–2293

    Article  CAS  PubMed  Google Scholar 

  26. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu X, Chu K, Lu C, Zhao J, Xie D, Wu M, Cheng S, Liu S (2012) MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 56:389–396

    Article  CAS  PubMed  Google Scholar 

  27. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ (2012) MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 228:204–215

    Article  CAS  PubMed  Google Scholar 

  28. Jahid S, Sun J, Edwards RA, Dizon D, Panarelli NC, Milsom JW, Sikandar SS, Gümüs ZH, Lipkin SM (2012) miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov 2:540–553

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y, JROSG Working Subgroup of Gastrointestinal Cancers (2010) Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys 77:734–742

    Article  PubMed  Google Scholar 

  30. Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X, Zhao Z, Kong KL, Dong S, Song Y, Chan TH, Guan XY (2012) MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene 31:2298–2308

    Article  CAS  PubMed  Google Scholar 

  31. Ansari D, Rosendahl A, Elebro J, Andersson R (2011) Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg 98:1041–1055

    Article  CAS  PubMed  Google Scholar 

  32. Winter JM, Yeo CJ, Brody JR (2013) Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 107:15–22

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National High Technology Research and Development Program (863 Program, 2014AA020609), China.

Author Contributions

conception and design of the study (Y.P. Z. and J.C. G.), data collection (L. Z., J.C. G. and J. L.), data analysis and interpretation (Q.Q. S., Z.Y. L. and W.X. Z.), manuscript writing (J.C. G. and L. Z.), manuscript editing (Q.Q. S., T.P. Z. and L. Y.), critical revision (Y.P. Z.).

Obtaining Funding

National High Technology Research and Development Program (863 Program, 2014AA020609), China.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun-Chao Guo or Yu-Pei Zhao.

Additional information

Li Zhou and Jian Li contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. S1

Influences of tumoral MTSS1 expression on overall survival in subgroups of pancreatic cancer after resection. High expression, solid line; low expression, dashed line. (A) female patients (low: n = 12; high: n = 44; P = 0.003); (B) patients <65 years (low: n = 28; high: n = 77; P = 0.002); (C) tumors ≤4 cm (low: n = 15; high: n = 53; P < 0.001); (D) G1-2 tumors (low: n = 27; high: n = 77; P = 0.049); (E) G3-4 tumors (low: n = 13; high: n = 34; P = 0.007); (F) tumors without PNI (low: n = 21; high: n = 64; P = 0.025); (G) T1-2 tumors (low: n = 29; high: n = 84; P = 0.014); (H) T3 tumors (low: n = 14; high: n = 33; P = 0.024); (I) N0 tumors (low: n = 21; high: n = 74; P = 0.008). MTSS1, metastasis suppressor 1; PC, pancreatic cancer; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, undifferentiated; PNI, perineural invasion; T, tumor; N, lymph node. (GIF 45 kb)

High resolution image

(TIFF 624 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, L., Li, J., Shao, QQ. et al. Expression and Significances of MTSS1 in Pancreatic Cancer. Pathol. Oncol. Res. 22, 7–14 (2016). https://doi.org/10.1007/s12253-015-9963-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-015-9963-2

Keywords

Navigation